Skip to content
20-F

Annual Report (Foreign)

Zepp Health Corp ZEPP

0001104659-26-048127

← back to feed
Filed
Apr 24, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2025 · Dec 31, 2025 254.43M sh
Shares Diluted FY 2025 · Dec 31, 2024 258.88M sh
Shares Diluted FY 2025 · Dec 31, 2023 243.14M sh
Stock Repurchased FY 2025 · Dec 31, 2025 $1.24M
Stock Repurchased FY 2025 · Dec 31, 2024 $2.28M
Stock Repurchased restated FY 2025 · Dec 31, 2023 $2.52M
Capex FY 2025 · Dec 31, 2025 $516K
Capex FY 2025 · Dec 31, 2024 $1.4M
Capex restated FY 2025 · Dec 31, 2023 $1.6M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$25.69M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$24.39M
Operating Cash Flow restated FY 2025 · Dec 31, 2023 $42.6M
Long Term Debt FY 2025 · Dec 31, 2025 $59.48M
Long Term Debt FY 2025 · Dec 31, 2024 $75.24M
Cash And Equivalents FY 2025 · Dec 31, 2025 $57.05M
Cash And Equivalents FY 2025 · Dec 31, 2024 $91.07M
Cash And Equivalents FY 2025 · Dec 31, 2023 $133.67M
Stockholders Equity FY 2025 · Dec 31, 2025 $214.53M
Stockholders Equity FY 2025 · Dec 31, 2024 $251.59M
Current Liabilities FY 2025 · Dec 31, 2025 $286.84M
Current Liabilities FY 2025 · Dec 31, 2024 $195.37M
Total Liabilities FY 2025 · Dec 31, 2025 $350.3M
Total Liabilities FY 2025 · Dec 31, 2024 $275.87M
Current Assets FY 2025 · Dec 31, 2025 $293.53M
Current Assets FY 2025 · Dec 31, 2024 $251.56M
Total Assets FY 2025 · Dec 31, 2025 $564.84M
Total Assets FY 2025 · Dec 31, 2024 $528.59M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.16
Eps Diluted FY 2025 · Dec 31, 2024 −$0.29
Eps Diluted restated FY 2025 · Dec 31, 2023 −$0.13
Eps Basic FY 2025 · Dec 31, 2025 −$0.16
Eps Basic FY 2025 · Dec 31, 2024 −$0.29
Eps Basic restated FY 2025 · Dec 31, 2023 −$0.13
Sga Expense FY 2025 · Dec 31, 2025 $29.27M
Sga Expense FY 2025 · Dec 31, 2024 $24.85M
Sga Expense restated FY 2025 · Dec 31, 2023 $26.78M
Rd Expense FY 2025 · Dec 31, 2025 $45.32M
Rd Expense FY 2025 · Dec 31, 2024 $46.16M
Rd Expense restated FY 2025 · Dec 31, 2023 $51.5M
Net Income FY 2025 · Dec 31, 2025 −$40.07M
Net Income FY 2025 · Dec 31, 2024 −$75.73M
Net Income restated FY 2025 · Dec 31, 2023 −$31.02M
Operating Income FY 2025 · Dec 31, 2025 −$29.23M
Operating Income FY 2025 · Dec 31, 2024 −$47.25M
Operating Income restated FY 2025 · Dec 31, 2023 −$30.45M
Gross Profit FY 2025 · Dec 31, 2025 $99.19M
Gross Profit FY 2025 · Dec 31, 2024 $70.23M
Gross Profit restated FY 2025 · Dec 31, 2023 $92.36M
Revenue FY 2025 · Dec 31, 2025 $258.9M
Revenue FY 2025 · Dec 31, 2024 $182.6M
Revenue restated FY 2025 · Dec 31, 2023 $352.86M
Short Term Investments FY 2025 · Dec 31, 2024 $997K